Physician Info

The transition of patients to HFA-propelled inhalers is an important issue in asthma care today, even though this decision was made years ago. Because there are no significant medical safety or efficacy differences between CFC and HFA devices, clinicians may think there are no differences that are important to communicate to patients. The reality is that switching a patient to an HFA albuterol device requires active involvement of the provider to ensure a smooth transition. Notable differences among HFA- and CFC-propelled inhalers, including the difference in taste and spray, can make some patients reluctant to use HFA devices. Other differences require patients to maintain their devices differently. Teaching and helping patients understand these differences and reassuring them that they are still getting the same rescue medication may help pave the way toward a smoother transition to HFA albuterol.

HFA Today can help facilitate this transition by providing clinician and patient educational tools and materials.